These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28656229)

  • 21. Role of podoplanin in potentially malignant disorders and oral squamous cell carcinoma and its correlation with lymphangiogenesis.
    Parhar S; Kaur H; Vashist A; Verma S
    Indian J Cancer; 2015; 52(4):617-22. PubMed ID: 26960495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer.
    Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X
    World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of podoplanin-positive cancer-associated fibroblasts in surgically resected primary lung adenocarcinoma predicts a shorter progression-free survival period in patients with recurrences who received platinum-based chemotherapy.
    Koriyama H; Ishii G; Yoh K; Neri S; Morise M; Umemura S; Matsumoto S; Niho S; Ohmatsu H; Tsuboi M; Goto K; Ochiai A
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1163-70. PubMed ID: 25446816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of keratinocyte growth factor/fibroblast growth factor-7 and its receptor in human lung cancer: correlation with tumour proliferative activity and patient prognosis.
    Yamayoshi T; Nagayasu T; Matsumoto K; Abo T; Hishikawa Y; Koji T
    J Pathol; 2004 Sep; 204(1):110-8. PubMed ID: 15307144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis.
    Hu L; Zhang P; Mei Q; Sun W; Zhou L; Yin T
    BMC Cancer; 2020 May; 20(1):424. PubMed ID: 32408907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: podoplanin in fibroblast functions for tumor progression.
    Hoshino A; Ishii G; Ito T; Aoyagi K; Ohtaki Y; Nagai K; Sasaki H; Ochiai A
    Cancer Res; 2011 Jul; 71(14):4769-79. PubMed ID: 21610106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation.
    Yoshida T; Ishii G; Goto K; Neri S; Hashimoto H; Yoh K; Niho S; Umemura S; Matsumoto S; Ohmatsu H; Iida S; Niimi A; Nagai K; Ohe Y; Ochiai A
    Clin Cancer Res; 2015 Feb; 21(3):642-51. PubMed ID: 25388165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
    Goodwin J; Neugent ML; Lee SY; Choe JH; Choi H; Jenkins DMR; Ruthenborg RJ; Robinson MW; Jeong JY; Wake M; Abe H; Takeda N; Endo H; Inoue M; Xuan Z; Yoo H; Chen M; Ahn JM; Minna JD; Helke KL; Singh PK; Shackelford DB; Kim JW
    Nat Commun; 2017 May; 8():15503. PubMed ID: 28548087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppressive tumor microenvironment of usual interstitial pneumonia-associated squamous cell carcinoma of the lung.
    Ueda T; Aokage K; Nishikawa H; Neri S; Nakamura H; Sugano M; Tane K; Miyoshi T; Kojima M; Fujii S; Kuwata T; Ochiai A; Kusumoto M; Suzuki K; Tsuboi M; Ishii G
    J Cancer Res Clin Oncol; 2018 May; 144(5):835-844. PubMed ID: 29435735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma.
    Kawase A; Ishii G; Nagai K; Ito T; Nagano T; Murata Y; Hishida T; Nishimura M; Yoshida J; Suzuki K; Ochiai A
    Int J Cancer; 2008 Sep; 123(5):1053-9. PubMed ID: 18546264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma.
    Suzuki J; Aokage K; Neri S; Sakai T; Hashimoto H; Su Y; Yamazaki S; Nakamura H; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Tsuboi M; Ishii G
    Lung Cancer; 2021 Mar; 153():1-10. PubMed ID: 33429158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial-mesenchymal transition (EMT).
    Jiao J; Zhao X; Liang Y; Tang D; Pan C
    Biochem Biophys Res Commun; 2015 Oct; 466(3):327-32. PubMed ID: 26362179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunophenotypic features of metastatic lymph node tumors to predict recurrence in N2 lung squamous cell carcinoma.
    Matsuwaki R; Ishii G; Zenke Y; Neri S; Aokage K; Hishida T; Yoshida J; Fujii S; Kondo H; Goya T; Nagai K; Ochiai A
    Cancer Sci; 2014 Jul; 105(7):905-11. PubMed ID: 24814677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
    Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
    Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of circulating tumor cells with podoplanin expression in patients with locally advanced or metastatic head and neck squamous cell carcinoma.
    Hsieh JC; Lin HC; Huang CY; Hsu HL; Wu TM; Lee CL; Chen MC; Wang HM; Tseng CP
    Head Neck; 2015 Oct; 37(10):1448-55. PubMed ID: 24844673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma.
    Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D
    J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High podoplanin expression in cancer cells predicts lower incidence of nodal metastasis in patients with lung squamous cell carcinoma.
    Suzuki H; Onimaru M; Koga T; Takeshita M; Yano T; Maehara Y; Nakamura S; Sueishi K
    Pathol Res Pract; 2011 Feb; 207(2):111-5. PubMed ID: 21194851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma.
    Chuang WY; Yeh CJ; Chao YK; Liu YH; Chang YS; Tseng CK; Chang HK; Wan YL; Hsueh C
    Int J Clin Exp Pathol; 2014; 7(8):4847-56. PubMed ID: 25197355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival.
    de Vicente JC; Santamarta TR; Rodrigo JP; García-Pedrero JM; Allonca E; Blanco-Lorenzo V
    Virchows Arch; 2015 May; 466(5):549-58. PubMed ID: 25726183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.